India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 – 2028
Indian Non-Invasive Prenatal Testing (NIPT) Market size is expected to reach USD 62 million by 2028. The market is expected to expand at a CAGR of more than 11% from 2022 to 2028.
India Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing. The market shows high potential for growth in the future.
This new market report presents a comprehensive study of the entire Indian non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the India non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in India.
This Comprehensive India’s Non-Invasive Prenatal Testing Market Research Report Provides:
To Analyse the Historical Growth in the Market Size of the India Non–Invasive Prenatal Testing Market from 2018 to 2021
To Estimate and Forecast the Market Size of the India Non–Invasive Prenatal Testing Market from 2022 to 2028 and Growth Rate until 2028
Evaluates the Number of NIPT Tests Performed in India with Six Years Forecast
Assessment of Market Potential and Opportunities for this Innovation-Driven India Non–Invasive Prenatal Testing Market with Six Years Forecast
Meticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
Detailed Insights into the Regulatory Framework of the India Non–Invasive Prenatal Testing Market
Features Reimbursement Patterns of the India Non–Invasive Prenatal Testing Market
Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development
The Leading Companies for the Indian Non–Invasive Prenatal Testing Market are Listed Below:
Medgenome
DNA Labs India
LifeCell
Apollo Centre for Fetal Medicine
Igenomix India
Fortis Healthcare Limited
DNA Forensics Laboratory Pvt. Ltd.
Thyrocare Technologies Limited
Key Questions Answered in this Report:
What is the current scenario of the Indian non–invasive prenatal testing market?
What is the total market size and forecast (until 2028) for the Indian non–invasive prenatal testing market?
How has the potential Indian market performed so far and how will it perform in the coming years?
How many NIPT tests were performed in India during 2018 – 2028?
What are the key marketed NIPT tests available in India?
What are the major drivers of the Indian non–invasive prenatal testing market?
What are the major inhibitors of the Indian non–invasive prenatal testing market?
What is the reimbursement pattern in the Indian non–invasive prenatal testing market?
What is the regulatory framework in the Indian non–invasive prenatal testing market?
What are the major deals and agreement happenings in the non–invasive prenatal testing market?
Who are the top Indian market players? What are their happenings, current developments, and scenarios?
How is the Indian market predicted to develop in the future?
- 1. Executive Summary
- 2. India Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028)
- 3. India Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028)
- 4. India Actual Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028)
- 5. India Potential Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028)
- 6. India Non–Invasive Prenatal Testing Market Growth Drivers and Challenges
- 7. Non–Invasive Prenatal Testing Comparative Analysis
- 8. Reimbursement Environment of the India Non-Invasive Prenatal Testing Market
- 9. Regulation Framework of the India Non-Invasive Prenatal Testing Market
- 10. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
- 10.1 Collaboration Deals
- 10.2 Venture Capital Investment
- 10.3 Mergers and Acquisitions
- 10.4 Exclusive Agreement
- 10.5 Licensing Agreement
- 10.6 Distribution Agreement
- 10.7 Partnership Deals
- 11. Key Companies Analysis
- 11.1 Medgenome
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Recent Development
- 11.2 DNA Labs India
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Recent Development
- 11.3 LifeCell
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Recent Development
- 11.4 Apollo Centre for Fetal Medicine
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Recent Development
- 11.5 Igenomix India
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Recent Development
- 11.6 Fortis Healthcare Limited
- 11.6.1 Business Overview
- 11.6.2 Product Portfolio
- 11.6.3 Recent Development
- 11.7 DNA Forensics Laboratory Pvt. Ltd
- 11.7.1 Business Overview
- 11.7.2 Product Portfolio
- 11.7.3 Recent Development
- 11.8 Thyrocare Technologies Limited
- 11.8.1 Business Overview
- 11.8.2 Product Portfolio
- 11.8.3 Recent Development
- List of Tables:
- Table 7–1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
- Table 10–1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
- Table 10–2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
- Table 10–3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
- Table 10–4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
- Table 10–5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
- Table 10–6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
- Table 10–7: Partnership Deals in the Non–Invasive Prenatal Testing Market
- List of Figures:
- Figure 2–1: India Actual NIPT Test Volume (Number),2018 – 2021
- Figure 2–2: India Actual NIPT Test Volume Forecast (Number),2022 – 2028
- Figure 3–1: India Potential NIPT Test Volume (Number),2018 – 2021
- Figure 3–2: India Potential NIPT Test Volume Forecast (Number),2022 – 2028
- Figure 4–1: India Actual NIPT Test Market Size (Million US$),2018 – 2021
- Figure 4–2: India Actual NIPT Test Market Size Forecast (Million US$),2022 – 2028
- Figure 5–1: India Potential NIPT Test Market Size (Million US$),2018 – 2021
- Figure 5–2: India Potential NIPT Test Market Size Forecast (Million US$),2022 – 2028
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook